Home Cart 0 Sign in  
X

[ CAS No. 23012-14-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 23012-14-8
Chemical Structure| 23012-14-8
Chemical Structure| 23012-14-8
Structure of 23012-14-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 23012-14-8 ]

Related Doc. of [ 23012-14-8 ]

Alternatived Products of [ 23012-14-8 ]

Product Details of [ 23012-14-8 ]

CAS No. :23012-14-8 MDL No. :MFCD04114940
Formula : C6H7NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :UBESIXFCSFYQNK-UHFFFAOYSA-N
M.W : 141.13 Pubchem ID :2763217
Synonyms :

Calculated chemistry of [ 23012-14-8 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.33
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 32.59
TPSA : 52.33 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.53 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.74
Log Po/w (XLOGP3) : 0.89
Log Po/w (WLOGP) : 0.85
Log Po/w (MLOGP) : -0.43
Log Po/w (SILICOS-IT) : 0.94
Consensus Log Po/w : 0.8

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.45
Solubility : 5.03 mg/ml ; 0.0357 mol/l
Class : Very soluble
Log S (Ali) : -1.57
Solubility : 3.77 mg/ml ; 0.0267 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.69
Solubility : 2.86 mg/ml ; 0.0203 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.25

Safety of [ 23012-14-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 23012-14-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 23012-14-8 ]
  • Downstream synthetic route of [ 23012-14-8 ]

[ 23012-14-8 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 23012-14-8 ]
  • [ 23012-13-7 ]
Reference: [1] Heterocycles, 2000, vol. 53, # 5, p. 1167 - 1170
[2] Journal of the Chemical Society, 1947, p. 96,100
[3] Journal of Organic Chemistry, 1999, vol. 64, # 13, p. 4995 - 4998
  • 2
  • [ 2949-22-6 ]
  • [ 23012-14-8 ]
YieldReaction ConditionsOperation in experiment
84%
Stage #1: With formic acid In tetrahydrofuran for 0.5 h;
Stage #2: With triethylamine In tetrahydrofuran at 20℃; for 1 h; Heating / reflux
To a sol. of formic acid (8.62 mL, 228 mmol) in dry THF (200 mL) was added portionwise CDI (37.05 g, 228 mmol), whereas a gas evolution occurred. The mixture was stirred for 30 min, and a sol. of ethyl isocyanoacetate (25 mL, 228 mmol) in Et3N (60.5 mL, 434mmol) was added to the reaction mixture. The mixture was stirred at rt for 1 h, then under reflux overnight. The reaction mixture was allowed to cool to rt. Water was added, and the mixture was extracted with Et2O (3x). The combined org. extracts were dried over MgSO4, filtered and concentrated. Purification of the residue by FC (EtOAc / heptane; 1:5 -> 1:3 - 1:1) yielded the title compound (27.2 g, 84percent). LC-MS: tR = 0.58, ES+: 142.07.
Reference: [1] Patent: WO2006/21402, 2006, A1, . Location in patent: Page/Page column 33-34
  • 3
  • [ 64-18-6 ]
  • [ 2999-46-4 ]
  • [ 23012-14-8 ]
Reference: [1] Organic Letters, 2018, vol. 20, # 19, p. 6027 - 6032
[2] Liebigs Annalen der Chemie, 1979, p. 1370 - 1387
[3] Patent: US2009/170907, 2009, A1, . Location in patent: Page/Page column 47
  • 4
  • [ 10535-67-8 ]
  • [ 2999-46-4 ]
  • [ 23012-14-8 ]
Reference: [1] Heterocycles, 2012, vol. 86, # 2, p. 1003 - 1008
  • 5
  • [ 2999-46-4 ]
  • [ 530-62-1 ]
  • [ 23012-14-8 ]
Reference: [1] Heterocycles, 2000, vol. 53, # 5, p. 1167 - 1170
  • 6
  • [ 3154-51-6 ]
  • [ 23012-14-8 ]
Reference: [1] Liebigs Annalen der Chemie, 1979, p. 1370 - 1387
  • 7
  • [ 23012-14-8 ]
  • [ 74-88-4 ]
  • [ 10200-43-8 ]
Reference: [1] Organic and Biomolecular Chemistry, 2009, vol. 7, # 4, p. 647 - 650
  • 8
  • [ 23012-14-8 ]
  • [ 23012-15-9 ]
Reference: [1] Heterocycles, 2012, vol. 86, # 2, p. 1003 - 1008
[2] Helvetica Chimica Acta, 1960, vol. 43, p. 1522 - 1530
  • 9
  • [ 23012-14-8 ]
  • [ 118994-84-6 ]
Reference: [1] Beilstein Journal of Organic Chemistry, 2014, vol. 10, p. 2222 - 2229
[2] European Journal of Organic Chemistry, 2015, vol. 2015, # 3, p. 647 - 654
[3] Organic Letters, 2007, vol. 9, # 10, p. 1875 - 1878
[4] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 11, p. 2928 - 2930
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 23012-14-8 ]

Esters

Chemical Structure| 10200-43-8

[ 10200-43-8 ]

Ethyl 2-methyloxazole-4-carboxylate

Similarity: 0.88

Chemical Structure| 177760-52-0

[ 177760-52-0 ]

Ethyl 2-aminooxazole-4-carboxylate

Similarity: 0.85

Chemical Structure| 85806-67-3

[ 85806-67-3 ]

Methyl 2-methyloxazole-4-carboxylate

Similarity: 0.85

Chemical Structure| 460081-20-3

[ 460081-20-3 ]

Ethyl 2-bromooxazole-4-carboxylate

Similarity: 0.84

Chemical Structure| 32968-44-8

[ 32968-44-8 ]

Ethyl 5-methyloxazole-4-carboxylate

Similarity: 0.84

Related Parent Nucleus of
[ 23012-14-8 ]

Oxazoles

Chemical Structure| 23012-13-7

[ 23012-13-7 ]

Oxazole-4-carboxylic acid

Similarity: 0.92

Chemical Structure| 10200-43-8

[ 10200-43-8 ]

Ethyl 2-methyloxazole-4-carboxylate

Similarity: 0.88

Chemical Structure| 177760-52-0

[ 177760-52-0 ]

Ethyl 2-aminooxazole-4-carboxylate

Similarity: 0.85

Chemical Structure| 85806-67-3

[ 85806-67-3 ]

Methyl 2-methyloxazole-4-carboxylate

Similarity: 0.85

Chemical Structure| 460081-20-3

[ 460081-20-3 ]

Ethyl 2-bromooxazole-4-carboxylate

Similarity: 0.84